Biotech & Life Sciences Startups

C

Cellbricks Therapeutics

Germany

Cellbricks Therapeutics is a Berlin-based regenerative medicine company spun out of the Technical University of Berlin. It develops light-based 3D bioprinting and AI-driven tissue engineering to produce scalable, immune-compatible, vascularized, patient-specific soft tissue implants and biofabricated tissue therapeutics for indications such as adipose tissue repair, liver patches and breast reconstruction. Its platform combines proprietary DLP light-based bioprinting, custom biomaterials, synthetic biology and AI-driven process control to enable high cell viability, multi-material printing and GMP-aligned manufacturing. Founded in 2016, the company focuses on advancing preclinical programs toward clinical studies.

T

Tombot

United States

Tombot is a Santa Clarita, California company making health-and-wellness robotic companion animals. Its flagship, Jennie, is a fully autonomous robotic puppy that mimics an 8-10 week-old dog to provide emotional support and comfort for seniors with dementia or mild cognitive impairment, as well as people coping with anxiety, loneliness, autism and PTSD. Founded and led by CEO Tom Stevens, the company has amassed more than 23,000 pre-order and waitlist customers ahead of a planned Fall 2026 launch.

L

Lucida Medical

United Kingdom

Lucida Medical is a Cambridge-based AI medtech company that develops artificial intelligence software to support the detection, diagnosis, and management of cancer. Its flagship product, Pi (Prostate Intelligence), is a CE-marked medical device that analyses prostate MRI scans to identify suspicious lesions and generate risk scores, assisting radiologists in detecting clinically significant prostate cancer. The system is trained on thousands of patient scans and is deployed across multiple NHS hospitals in the UK, with EU approval and plans to seek US FDA approval. Founded in 2019 by Anthony and Evis Sala.

A

Acumen Pharmaceuticals, Inc.

Morocco

Acumen Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing targeted therapies for Alzheimer’s disease by attacking toxic soluble amyloid beta oligomers (AβOs). Its lead program, sabirnetug (ACU193), is a monoclonal antibody designed to selectively neutralize AβOs and is being evaluated in the Phase 2 ALTITUDE-AD trial. The company is also advancing an Enhanced Brain Delivery (EBD™) program that leverages J-Brain Cargo® technology to improve blood–brain barrier penetration and enable subcutaneous dosing. Acumen is headquartered in Newton, Massachusetts and focuses on therapies for early Alzheimer’s disease.

E

Endovascular Engineering

United States

Creating innovative venous thrombectomy solutions. | Endovascular Engineering, Inc. ("E2"), is a mission driven, venture-backed company focusing on the development and deployment of groundbreaking clot removal technologies that target venous thromboembolism.

I

IceCure Medical Ltd.

Israel

IceCure Medical develops minimally-invasive cryoablation systems that destroy tumors by freezing them, using a liquid-nitrogen based technology. Its ProSense platform enables quick, convenient office-based and CT-room procedures for indications including breast, kidney and lung cancers as well as palliative care. The company is headquartered in Caesarea, Israel and supports clinical adoption through published studies and physician resources.

G

Gilgamesh Pharma

United States

Gilgamesh Pharma is a clinical-stage neuroscience biotechnology company developing novel new chemical entities aimed at transforming psychiatric disease treatment toward rapid-acting and durable therapies. The company focuses on next-generation neuroplastogens, NMDAR antagonists, safer ibogaine analogs, and M1/M4 agonists, using an AI-powered discovery platform that combines behavioral, electrophysiology, and molecular neuroplasticity measures. Founded in 2019 and headquartered in New York, it targets mental health conditions with orally bioavailable, non-hallucinogenic compounds designed to improve safety and efficacy over first-generation psychedelics.

S

Saude Bliss

Brazil

Saude Bliss is a Brazilian insurtech startup providing an AI-powered platform for distributing health insurance to small and medium-sized businesses. Its core product features an AI agent named Fatima that generates quotes, compares insurance products, and issues policies while automating operational tasks for brokers. The company reached breakeven by end of 2025.

C

College Health TV

United States

College Health TV is a Durham, North Carolina-based streaming service delivering health and wellness video programming to college students at U.S. colleges and universities. It operates on a free, fully ad-supported (AVOD) model and provides participating institutions with a dedicated digital-signage player for placement in student health centers, recreation areas, and dining halls, covering evidence-based topics such as mental health, nutrition, fitness, and sexual health. Content is produced with peer health educators and refreshed monthly.